• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    DCAT Week ’19

    Temperature-Controlled Logistics

    Reducing Pill Burden

    Nasal Drug Delivery

    AI in Pharma: Transforming Data into Drugs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Nestlé Health Licenses Codexis’ CDX-6114

    SK, Arvelle Sign $530M Deal for Antiepileptic Drug

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Progenics Launches Mfg. Ops in NJ

    Charles River to Pay $510M for Citoxlab
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Progenics Launches Mfg. Ops in NJ

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour

    Haselmeier Acquires Drug Manufacturing License

    Emerald Health, Lonza Enter Large-Scale Mfg. Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour

    Recipharm Facilities Ready for EU Serialization

    Andrew Alliance, Sartorius Launch Research Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Nestlé Health Licenses Codexis’ CDX-6114

    Personalized Medicine: Getting More Out of Clinical Trials

    SK, Arvelle Sign $530M Deal for Antiepileptic Drug

    Charles River to Pay $510M for Citoxlab

    West, Swissfillon Enter Drug Delivery Partnership
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Former FDA Senior Executives Join PAREXEL

    Top Global Pharma Company to Implement ValGenesis' VLMS

    WCG, Prudentia Enter Pharmacovigilance Alliance

    ValGenesis VLMS Chosen to Digitize Validation Process

    Serialization Compliance: Understanding the Challenges
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Federal Equipment Company

    Ajinomoto Bio-Pharma Services

    Baxter BioPharma Solutions

    Vetter Pharma International GmbH

    Ascendia Pharmaceuticals
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Jubilant HollisterStier Contract Manufacturing & Services

    Vetter Pharma International GmbH

    Ajinomoto Bio-Pharma Services

    Federal Equipment Company

    Aphena Pharma Solutions, Inc.
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Evotec AG, Immuneering in Discovery Alliance

    Will leverage AI to discover novel small molecules for rare hereditary metabolic diseases

    Related CONTENT
    • Arix Bioscience Announces Formation of LAB591
    • Evotec Achieves €3M Sanofi Milestone
    • Evotec, Sanofi Close Strategic Licensing Deal
    • Slayback Appoints Global Affairs SVP
    • Evotec Achieves Bayer Milestone
    11.21.18
    Evotec AG has entered into a research collaboration with Immuneering Corp., a data-driven drug discovery provider, to discover novel small molecules for rare hereditary metabolic diseases. Financial details were not disclosed.

    Evotec will leverage its induced pluripotent stem cell (iPSC) platform and drug discovery capabilities and Immuneering will apply its Artificial Intelligence drug discovery platform in an effort to accelerate ligand identification for novel targets. As part of the collaboration, Evotec will use Immuneering's computational drug discovery platform Fluency to analyze public and proprietary data to help advance identification of novel drug candidates that can ultimately lead to new medicines for rare hereditary metabolic diseases.

    Dr. Cord Dohrmann, chief scientific officer of Evotec, said, "We are very excited to collaborate with Immuneering on its unique AI-driven approach to ligand identification. This is a significant opportunity to develop novel drugs targeting disorders of lysosomes that drive different clinical presentations in many rare genetic metabolic and neurodegenerative diseases with high unmet medical need. We look forward to exploring the powerful combination of these technologies and enhancing our drug discovery capabilities in our core areas of focus."

    Dr. Greg Koytiger, senior vice president and head of AI for Immuneering, said, "We are thrilled to combine Evotec's industry-leading iPSC platform with our AI platform, Fluency, to rapidly identify and functionally profile novel small molecule drugs for rare hereditary metabolic diseases. This not only accelerates the drug discovery process, but opens up new targets that are understudied or difficult to drug. Evotec's in-depth knowledge of targets of interest and their leading iPSC platform make them an ideal partner to transform in silico hits into breakthrough therapies. We look forward to integrating best in class experimental and computational approaches to break new ground together for the benefit of these patients."
    Related Searches
    • discovery
    • neurodegenerative diseases
    • collaboration
    • patients
    Suggested For You
    Evotec, Ferring Enter Strategic Collaboration Evotec, Ferring Enter Strategic Collaboration
    Evotec & Sanofi Launch LAB031 Evotec & Sanofi Launch LAB031
    APEIRON & LDC Enter Partnership APEIRON & LDC Enter Partnership
    Evotec, Almirall Sign Research Agreement Evotec, Almirall Sign Research Agreement
    Evotec, Celgene in Third Discovery and Development Pact Evotec, Celgene in Third Discovery and Development Pact
    CHDI Extends Evotec Collaboration CHDI Extends Evotec Collaboration
    Evotec, Novo Nordisk Enter Strategic Diabetes Alliance Evotec, Novo Nordisk Enter Strategic Diabetes Alliance
    Stealth & Evotec Advance New Compound Stealth & Evotec Advance New Compound
    Evotec AG, Haplogen Partner with Bayer in COPD Evotec AG, Haplogen Partner with Bayer in COPD
    Forge Therapeutics Achieves CARB-X Milestone Forge Therapeutics Achieves CARB-X Milestone
    Evotec Achieves Bayer Milestone Evotec Achieves Bayer Milestone
    Slayback Appoints Global Affairs SVP Slayback Appoints Global Affairs SVP
    Evotec, Sanofi Close Strategic Licensing Deal Evotec, Sanofi Close Strategic Licensing Deal
    Evotec Achieves €3M Sanofi Milestone Evotec Achieves €3M Sanofi Milestone
    Arix Bioscience Announces Formation of LAB591 Arix Bioscience Announces Formation of LAB591

    Related Breaking News

    • Breaking News | Drug Development | Industry News
      Nestlé Health Licenses Codexis’ CDX-6114

      Nestlé Health Licenses Codexis’ CDX-6114

      Novel, oral enzyme for phenylketonuria is Codexis’ first internally developed biotherapeutic candidate
      02.19.19

    • Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      SK, Arvelle Sign $530M Deal for Antiepileptic Drug

      SK, Arvelle Sign $530M Deal for Antiepileptic Drug

      Mark Altmeyer named president and chief executive of Arvelle
      02.15.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
      Passage Bio Officially Launches

      Passage Bio Officially Launches

      With $115.5M Series A, to develop AAV-delivered therapeutics to treat rare monogenic CNS diseases
      02.15.19


    • Bio News | Collaborations & Alliances | Drug Development | Industry News | Methods Development | R&D
      Axovant Announces Formation of Arvelle Therapeutics

      Axovant Announces Formation of Arvelle Therapeutics

      Along with the strategic transition of legacy small molecule team into the newly formed company
      02.15.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      AbCellera & Novartis Announce Collaboration

      AbCellera & Novartis Announce Collaboration

      AbCellera to apply technology to advance programs on up to ten targets elected by Novartis
      02.15.19

    • Breaking News | Clinical Trials | Industry News | Information Technology
      Boehringer, IBM Explore Blockchain Technology in Clinical Trials

      Boehringer, IBM Explore Blockchain Technology in Clinical Trials

      Aims to improve the quality of clinical trial processes and record keeping
      02.12.19


    • Breaking News | Industry News | Information Technology | Inspections | QA/QC | Regulatory Affairs | Validation
      Top Global Pharma Company to Implement ValGenesis

      Top Global Pharma Company to Implement ValGenesis' VLMS

      Paperless validation system aims to harmonize and standardize the validation process across all its global sites
      02.12.19

    • Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      NeoTX, MedImmune Announce Clinical Collaboration

      NeoTX, MedImmune Announce Clinical Collaboration

      To support Phase 1b/2 studies investigating ANYARA in combination with AstraZeneca's IMFINZI
      02.11.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      Eton & Sintetica Enter Supply Agreement

      Eton & Sintetica Enter Supply Agreement

      To obtain U.S. marketing rights to two high-volume, near-term product launch candidates.
      02.11.19


    • Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      3SBio, Verseau Establish Immuno-Oncology Devt. Collaboration

      3SBio, Verseau Establish Immuno-Oncology Devt. Collaboration

      3SBio will fund and conduct antibody development and GMP manufacturing
      02.11.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      MedPharm & Palvella Expand Partnership

      MedPharm & Palvella Expand Partnership

      For developing a new treatment for the debilitating rare disease, pachyonychia congenita
      02.11.19

    • Breaking News | Drug Development | Industry News
      IFM Therapeutics Launches Subsidiary

      IFM Therapeutics Launches Subsidiary

      IFM Due to advance cGAS/STING antagonists for serious inflammatory and autoimmune diseases
      02.11.19

    • Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D
      Pathios, Sygnature Announce Partnership

      Pathios, Sygnature Announce Partnership

      For an integrated drug discovery program against a novel G Protein-Coupled Receptor (GPCR) target
      02.07.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      Evotec & Galapagos Enter Global Collaboration

      Evotec & Galapagos Enter Global Collaboration

      Focused on a novel target for fibrosis and other indications
      02.07.19

    • Breaking News | Industry News | Information Technology
      Sharp Enhances IRT Solution

      Sharp Enhances IRT Solution

      Will invest $650,000; names Eddie Montoya IRT specialist.
      02.07.19

    Breaking News
    • Nestlé Health Licenses Codexis’ CDX-6114
    • SK, Arvelle Sign $530M Deal for Antiepileptic Drug
    • GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers
    • Progenics Launches Mfg. Ops in NJ
    • Charles River to Pay $510M for Citoxlab
    View Breaking News >
    CURRENT ISSUE

    January/February 2019

    • DCAT Week ’19
    • Temperature-Controlled Logistics
    • Reducing Pill Burden
    • Nasal Drug Delivery
    • AI in Pharma: Transforming Data into Drugs
    • Digitization: Pharma 4.0
    • Serialization Compliance: Understanding the Challenges
    • FDA & Data Integrity
    • Rising Demand for Lyophilized Products
    • Future Trends in the CDMO Space
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • privacy policy
    • term and condition
    • about us
    • contact us

    follow us

    Subscribe

    magazines

    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login